← Insider buys
KPTI

Karyopharm Therapeutics Inc. · Healthcare

EVP and Chief Commercial Officer Sohanya Roshan Cheng sold $34K of Karyopharm Therapeutics Inc.

Sold$34,045
$3.03Price
11,239Shares
−5%Stake

What KPTI did after the filing

Filed Mar 2, copier in the same day
The stock from Thu, Mar 2 close, $46.20
+40.3%
S&P 500, same days
+4.1%

Measured over 30 trading days, to the Apr 14 close.

Traded Wed, Mar 1. Filed Thu, Mar 2, 12:33 PM ET, during the session. Returns use the Mar 2 close and the Apr 14 close. Not investment advice.